Disease · MONDO_0021245
Trials17
Trials an Open Targets clinical report links to the disease, posted results first, then the largest. A trial is shown when the release's checks confirm its link to the disease and Drugs and targets shows its link to one of the disease's drugs. 1 more is not shown, since the checks do not confirm it.
1 to 17 of 17
Download this page as JSON| Trial | Title | Phase | Participants | Results first posted | Conditions | Drugs | Linked by | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03638622 | Low-cost Enabling Technology for Image-guided Photodynamic Therapy (PDT) of Oral Cancer Cancer. | Phase 1/2 | 30 | 2021-02-21 | Oral Cancer | AMINOLEVULINIC ACID | Its record names the disease | ClinicalTrials.gov |
| NCT00953849 | Vitamin D Plus Celecoxib Therapy to Stimulate Intratumoral Immune Reactivity | Phase 1/2 | 21 | 2016-12-21 | Mouth Neoplasms | CALCITRIOL, CELECOXIB | Its record names the disease | ClinicalTrials.gov |
| NCT01434394 | Neoadjuvant Erbitux Based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer | Phase 2/3 | 243 | Locally Advanced Malignant Neoplasm, Oral Cancer, Oropharyngeal Carcinoma, Effects of Chemotherapy | CETUXIMAB | Its record names the disease | ClinicalTrials.gov | |
| NCT00002747 | Surgery and Radiation Therapy With or Without Chemotherapy in Treating Patients With Mouth Cancer | Phase 3 | 240 | Head and Neck Cancer | CISPLATIN, FLUOROURACIL | Its record names the disease | ClinicalTrials.gov | |
| NCT01440270 | Neo-adjuvant Erbitux-based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer | Phase 2 | 145 | Locally Advanced Malignant Neoplasm, Oral Cancer, Oropharyngeal Carcinoma | CETUXIMAB | Its record names the disease | ClinicalTrials.gov | |
| NCT06876038 | Low-cost Screening and Image-guided Photodynamic Therapy (PDT) of Premalignant and Malignant Oral Lesions | Phase 2 | 65 | Oral Cancer, Oral Cavity Cancer, Oral Leukoplakia, Oral Lichen Planus, Oral Squamous Cell Carcinoma | AMINOLEVULINIC ACID | Its record names the disease | ClinicalTrials.gov | |
| NCT05865548 | Addition of Aspirin to Standard of Care in Oral Cancer | Phase 2/3 | 60 | Oral Cancer | ASPIRIN | Its record names the disease | ClinicalTrials.gov | |
| NCT07082621 | N Acetylcystene in Treatment of Radiotherapy Induced Oral Mucositis in Oral Cancer Patients | Not applicable | 40 | Oral Mucositis | ACETYLCYSTEINE | Its record names the disease | ClinicalTrials.gov | |
| NCT07015333 | Case Review of Patients With Betel Nut-induced Oral Cancer Treated With Pembrolizumab and Cetuximab | 31 | Oral Squamous Cell Carcinoma (OSCC) | CETUXIMAB, PEMBROLIZUMAB | Its record names the disease | ClinicalTrials.gov | ||
| NCT03288051 | Effects of Intraoperative, Goal-directed Crystalloid vs. Colloid Fluid Resuscitation on Free Flaps | Not applicable | 30 | Optimal Tissue Perfusion | DOBUTAMINE, NOREPINEPHRINE | Open Targets' reading of its record | ClinicalTrials.gov | |
| NCT06627270 | Antibiotic Treatment Effects on Intratumoral Bacteria Modulation in Surgical Patients With Oral Cancer | Phase 2 | 30 | Oral Squamous Cell Carcinoma, Oral Cancer, Head and Neck Cancer, Head and Neck Carcinoma | METRONIDAZOLE | Its record names the disease | ClinicalTrials.gov | |
| NCT03934294 | Acupuncture Effect on Digestion in Critically Ill Post-Operative Oral and Hypo-pharyngeal Cancer Patients | Not applicable | 28 | Oral Cancer, Hypopharyngeal Cancer | METOCLOPRAMIDE | Its record names the disease | ClinicalTrials.gov | |
| NCT05308732 | Safety and Tolerability of the Use of Copaiba in Patients With Oral Cancer Submitted to Radiotherapy | Phase 1 | 20 | Head and Neck Neoplasms, Mucositis Oral, Radiotherapy; Complications | CISPLATIN, FLUCONAZOLE | Its record names the disease | ClinicalTrials.gov | |
| NCT03843515 | Neoadjuvant Nivolumab for Oral Cancer Combined With FDG and Anti-PD-L1 PET/CT Imaging for Response Prediction | Phase 1 | 17 | Oral Cavity Squamous Cell Carcinoma | NIVOLUMAB | Its record names the disease | ClinicalTrials.gov | |
| NCT02946671 | Study of Pre-operative Combination Therapy With Mogamulizumab and Nivolumab Against Solid Cancer Patients | Phase 1 | 16 | Gastric Cancer, Esophageal Cancer, Lung Cancer, Renal Cancer, Oral Cancer | MOGAMULIZUMAB, NIVOLUMAB | Its record names the disease | ClinicalTrials.gov | |
| NCT00004094 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth, Pharynx, or Larynx | Phase 2 | Head and Neck Cancer | CARBOPLATIN, FLUOROURACIL, HYDROXYUREA, PACLITAXEL | Its record names the disease | ClinicalTrials.gov | ||
| NCT00004901 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Mouth Cancer | Phase 1/2 | Head and Neck Cancer | FLUOROURACIL, HYDROXYUREA | Its record names the disease | ClinicalTrials.gov |
diseases-2026-09-18-0.1.0
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/diseases/v1/MONDO_0021245/trials